nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status
|
Kim, Jin You |
|
2016 |
157 |
1 |
p. 31-40 |
artikel |
2 |
Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study
|
Agresti, Roberto |
|
2016 |
157 |
1 |
p. 179-189 |
artikel |
3 |
Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis
|
Lavaud, P. |
|
2016 |
157 |
1 |
p. 191-192 |
artikel |
4 |
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer
|
Rayson, Daniel |
|
2016 |
157 |
1 |
p. 109-116 |
artikel |
5 |
Compliance with hormonal therapy
|
Carson, Henry J. |
|
2016 |
157 |
1 |
p. 201 |
artikel |
6 |
Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
|
Gallagher, Christopher M. |
|
2016 |
157 |
1 |
p. 145-156 |
artikel |
7 |
Effect of polyphenols on glucose and lactate transport by breast cancer cells
|
Martel, F. |
|
2016 |
157 |
1 |
p. 1-11 |
artikel |
8 |
Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study
|
Connor, Avonne E. |
|
2016 |
157 |
1 |
p. 167-178 |
artikel |
9 |
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes
|
Purrington, Kristen S. |
|
2016 |
157 |
1 |
p. 117-131 |
artikel |
10 |
Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers
|
Paluch-Shimon, Shani |
|
2016 |
157 |
1 |
p. 157-165 |
artikel |
11 |
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
|
Green, Andrew R. |
|
2016 |
157 |
1 |
p. 65-75 |
artikel |
12 |
Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations
|
Murphy, Jeanne |
|
2016 |
157 |
1 |
p. 13-22 |
artikel |
13 |
Prognostic impact of breast cancer subtypes in elderly patients
|
Bergen, E. S. |
|
2016 |
157 |
1 |
p. 91-99 |
artikel |
14 |
Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer
|
Tabuchi, Yukiko |
|
2016 |
157 |
1 |
p. 55-63 |
artikel |
15 |
Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)
|
Hershman, Dawn L. |
|
2016 |
157 |
1 |
p. 133-143 |
artikel |
16 |
Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer
|
Felder, Tisha M. |
|
2016 |
157 |
1 |
p. 193-200 |
artikel |
17 |
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14
|
Chapman, Judith-Anne W. |
|
2016 |
157 |
1 |
p. 101-108 |
artikel |
18 |
The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer
|
Capper, Cameron P. |
|
2016 |
157 |
1 |
p. 23-30 |
artikel |
19 |
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
|
Thakkar, A. |
|
2016 |
157 |
1 |
p. 77-90 |
artikel |
20 |
Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown
|
Kim, Su-Hyeong |
|
2016 |
157 |
1 |
p. 41-54 |
artikel |